Methodology of a large prospective, randomised, open, blinded endpoint streamlined safety study of celecoxib versus traditional non-steroidal anti-inflammatory drugs in patients with osteoarthritis or rheumatoid arthritis: protocol of the standard care versus celecoxib outcome trial (SCOT)
Author(s): MacDonald TM, Mackenzie IS, Wei L, Hawkey CJ, Ford I, Collaborators SSG.
Bmj Open. 2013;3(1).
NIHR Acknowledged: No
|Professor Christopher Hawkey||Christopher Hawkey is Professor of Gastroenterology at the Nottingham Digestive Diseases Centre. His main interests are in the field of non-steroid anti-inflammatory drugs and inflammatory bowel disease. In both areas his approach is to try to identify…|